Acute Treatment of Bipolar II Depression

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Anticonvulsants; Lamotrigine; Lithium Carbonate

Criteria

Inclusion Criteria:

• Current diagnosis of bipolar II disorder

Exclusion Criteria:

• Use of lithium or lamotrigine

• Intolerance to lithium or lamotrigine

• Substance abuse or dependence within the last month

• Suicidal thoughts

• Unstable medical conditions

• Pregnancy or breast-feeding

• Stable on current medications

• Use of fluoxetine (Prozac) within 2 weeks of study

• Require an antipsychotic medication

• Do not speak or read English